drugset / Trial / NCT03639480
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety and efficacy of CJ-30061 compared with amlodipine/valsartan combination therapy and valsartan/atorvastatin combination therapy in hypertensive patients with hyperlipidemia
Timeline
- Start
- 2017-10-13
- Primary completion
- 2018-10
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 10 mg | — |
| Comparator | Atorvastatin | Small molecule | 40 mg | — |
| Comparator | Valsartan | Small molecule | 160 mg | — |